BioCentury
ARTICLE | Company News

Alopexx Pharmaceuticals, sanofi-aventis deal

November 10, 2014 8:00 AM UTC

Sanofi (formerly sanofi-aventis Group) disclosed in its 3Q14 earnings that it and Alopexx agreed to terminate a 2009 deal under which Sanofi gained exclusive, worldwide rights to SAR279356, which is...